KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Current Assets (2016 - 2026)

West Pharmaceutical Services has reported Current Assets over the past 18 years, most recently at $1.8 billion for Q1 2026.

  • Quarterly Current Assets rose 25.34% to $1.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Mar 2026, up 25.34% year-over-year, with the annual reading at $2.0 billion for FY2025, 28.61% up from the prior year.
  • Current Assets was $1.8 billion for Q1 2026 at West Pharmaceutical Services, down from $2.0 billion in the prior quarter.
  • Over five years, Current Assets peaked at $2.0 billion in Q4 2025 and troughed at $1.5 billion in Q1 2025.
  • The 5-year median for Current Assets is $1.8 billion (2022), against an average of $1.8 billion.
  • Biggest five-year swings in Current Assets: dropped 21.38% in 2024 and later increased 28.61% in 2025.
  • Tracing WST's Current Assets over 5 years: stood at $1.9 billion in 2022, then grew by 0.88% to $1.9 billion in 2023, then decreased by 20.57% to $1.5 billion in 2024, then increased by 28.61% to $2.0 billion in 2025, then dropped by 7.65% to $1.8 billion in 2026.
  • According to Business Quant data, Current Assets over the past three periods came in at $1.8 billion, $2.0 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.